G35
Conditions
Interventions
Group 1: Every six month the physician fills the medical data into a database. Patients will be asked to additionally complete a paper-based questionnaire. A follow-up of the medical and patient-based
Sponsors
Krankheitsbezogene Kompetenznetz Multiple Sklerose e.V.
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: MS patients 18 years and older who are receiving Tysabri therapy (de novo or ongoing treatment with Tysabri).
Exclusion criteria
Exclusion criteria: Patients without a diagnosis of MS expect of Patients with CIS, other therapies than Tysabri or younger than 18 years.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome the incidence, type and characteristics of adverse events in MS patients treated with Tysabri in routine clinical care. | — |
Secondary
| Measure | Time frame |
|---|---|
| For the secondary objective the following factors will be evaluated: a) EDSS progression b) Annual relapse rate. The Expanded Disability Status Scale (EDSS by Kurtzke) will be recorded every six month. | — |
Countries
Germany
Contacts
Public ContactTysabri-Daten-Register REGIMS Team
Institut für Epidemiologie und SozialmedizinWestfälische Wilhelms-Universität Münster
Outcome results
None listed